Clinical trials: Asthma Crisis
Asthma
Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis
Study to evaluate the bronchodilator efficacy and safety of a fixed combination of salbutamol sulfate (120 mcg) + ipratropium bromide (20mcg) (Combivent® MDI) in aerosol plus spacer in adult patients with moderate-to-severe…
- Trial name
- NCT02182700
- Testing
- salbutamol sulfate + ipratropium bromide
- Volunteers
- 47 people
- Sponsor
- Boehringer Ingelheim